Literature DB >> 12379651

Effect of charge reversal mutations on the ligand- and membrane-binding properties of liver fatty acid-binding protein.

Joanna K Davies1, Robert M Hagan, David C Wilton.   

Abstract

Liver fatty acid-binding protein (FABP) is able to bind to anionic phospholipid vesicles under conditions of low ionic strength. This binding results in the release of ligand, the fluorescent fatty acid analogue 11-dansylaminoundecanoic acid (DAUDA), with loss of fluorescence intensity (Davies, J. K., Thumser, A. E. A., and Wilton, D. C. (1999) Biochemistry 38, 16932-16940). Using a strategy of charge reversal mutagenesis, the potential role of specific cationic residues in promoting interfacial binding of FABP to anionic phospholipid vesicles has been investigated. Cationic residues chosen included those within the alpha-helical region (Lys-20, Lys-31, and Lys-33) and those that make a significant contribution to the positive surface potential of the protein (Lys-31, Lys-36, Lys-47, Lys-57, and Arg-126). Only three cationic residues make a significant contribution to interfacial binding, and these residues (Lys-31, Lys-36, and Lys-57) are all located within the ligand portal region, where the protein may be predicted to exhibit maximum disorder. The binding of tryptophan mutants, F3W, F18W, and C69W, to dioleoylphosphatidylglycerol vesicles, containing 5 mol% of the fluorescent phospholipid dansyldihexadecanoylphosphatidylethanolamine, was monitored by fluorescence resonance energy transfer (FRET). All three mutants showed enhanced dansyl fluorescence due to FRET on addition of phospholipid to protein; however, this fluorescence was considerably greater with the F3W mutant, consistent with the N-terminal region of the protein coming in close proximity to the phospholipid interface. These results were confirmed by succinimide quenching studies. Overall, the results indicate that the portal region of liver FABP and specifically Lys-31, Lys-36, and Lys-57 are involved in the interaction with the interface of anionic vesicles and that the N-terminal region of the protein undergoes a conformational change, resulting in DAUDA release.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12379651     DOI: 10.1074/jbc.M208141200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

Review 1.  The effect of charge reversal mutations in the alpha-helical region of liver fatty acid binding protein on the binding of fatty-acyl CoAs, lysophospholipids and bile acids.

Authors:  Robert M Hagan; Joanna K Davies; David C Wilton
Journal:  Mol Cell Biochem       Date:  2002-10       Impact factor: 3.396

2.  Interaction of enterocyte FABPs with phospholipid membranes: clues for specific physiological roles.

Authors:  Lisandro J Falomir-Lockhart; Gisela R Franchini; María Ximena Guerbi; Judith Storch; Betina Córsico
Journal:  Biochim Biophys Acta       Date:  2011-04-22

3.  Liver fatty acid-binding protein (L-FABP) promotes cellular angiogenesis and migration in hepatocellular carcinoma.

Authors:  Chung-Yu Ku; Yu-Huei Liu; Hsuan-Yuan Lin; Shao-Chun Lu; Jung-Yaw Lin
Journal:  Oncotarget       Date:  2016-04-05

Review 4.  Structural and Dynamic Determinants of Molecular Recognition in Bile Acid-Binding Proteins.

Authors:  Orsolya Toke
Journal:  Int J Mol Sci       Date:  2022-01-03       Impact factor: 5.923

5.  Probing the interaction of brain fatty acid binding protein (B-FABP) with model membranes.

Authors:  Fábio Dyszy; Andressa P A Pinto; Ana P U Araújo; Antonio J Costa-Filho
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.